VVT Med Inc.
VVT Med Inc. develops, manufactures, and commercializes minimally invasive, non-thermal, and nontumescent solutions for the treatment of varicose veins. It offers V-BLOCK, a treatment kit for leg vein; VAR-01, a treatment kit for leg varicosities; VAR-02, a treatment kit for shallow varicosities; VAR-P " 06, a treatment kit for perforant veins failure; and Spider-01, a treatment kit for spider ve… Read more
VVT Med Inc. (VVTM) - Total Liabilities
Latest total liabilities as of September 2025: CA$2.51 Million CAD
Based on the latest financial reports, VVT Med Inc. (VVTM) has total liabilities worth CA$2.51 Million CAD as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
VVT Med Inc. - Total Liabilities Trend (2022–2024)
This chart illustrates how VVT Med Inc.'s total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
VVT Med Inc. Competitors by Total Liabilities
The table below lists competitors of VVT Med Inc. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
va-Q-tec AG
PINK:VAQTF
|
USA | $103.39 Million |
|
SAIHEAT Limited
NASDAQ:SAIH
|
USA | $4.17 Million |
|
Minda Global Bhd
KLSE:5166
|
Malaysia | RM261.50 Million |
|
BMC
ST:BMC
|
Sweden | Skr31.94 Million |
|
Shreyans Industries Limited
NSE:SHREYANIND
|
India | ₹2.02 Billion |
|
SeaStar Medical Holding Corporation
NASDAQ:ICU
|
USA | $4.07 Million |
|
Addex Therapeutics Ltd
NASDAQ:ADXN
|
USA | $1.37 Million |
|
Tong Herr Resources Bhd
KLSE:5010
|
Malaysia | RM142.41 Million |
Liability Composition Analysis (2022–2024)
This chart breaks down VVT Med Inc.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.76 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -4.35 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 1.30 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how VVT Med Inc.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for VVT Med Inc. (2022–2024)
The table below shows the annual total liabilities of VVT Med Inc. from 2022 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | CA$7.37 Million | +17.93% |
| 2023-12-31 | CA$6.25 Million | +41.13% |
| 2022-12-31 | CA$4.42 Million | -- |